Curis reported 6.6 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Amgen 18.07 1.77 Jun/2026
AstraZeneca 25.34 4.25 Jun/2026
Bayer 4.14 0.74 Jun/2026
Bristol-Myers Squibb 16.14 7.06 Jun/2026
CSL 16.16 9.59 Dec/2025
Eli Lilly 32.9 7.37 Jun/2026
Exelixis 18.02 4.11 Jun/2026
Gilead Sciences 13.51 4.2 Jun/2026
GlaxoSmithKline 10.63 4.24 Jun/2026
Incyte 14.45 0.9 Jun/2026
Merck 32.26 15.74 Jun/2026
Novartis 22.41 2.24 Jun/2026
Pfizer 11.48 2.16 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Sanofi 18.96 7.12 Jun/2026
Takeda 24.4 22.12 Jun/2026
TG Therapeutics 19.64 7.65 Jun/2026